Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $156
Truist Securities analyst David Macdonald reiterates Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $156.
Share
Why It Matters
A stock expert still thinks Encompass Health is a good buy. They raised their price guess from $150 to $156, showing confidence.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.